Lévesque Renée, Savard Patrice, Canaud Bernard
Department of Medicine, Division of Nephrology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Canada.
Department of Medicine, Division of Infectious Disease, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Canada.
Infect Prev Pract. 2023 Jun 14;5(3):100292. doi: 10.1016/j.infpip.2023.100292. eCollection 2023 Sep.
Compliance with dialysis fluid ultrapurity standards is a paramount for online modalities. More than 200 dialysis fluid samples have been analyzed monthly for years in our two dialysis units, with compliant microbiological results until mid-2020.
In mid-2020, an unusual occurrence (30%) of contaminated dialysis fluids in dialysis units led us to investigate to determine the source.
Microbiological methods for aquaphilic bacteria culturing and endotoxin detection in dialysis fluids were routinely performed on a monthly basis for all dialysis machines. As the contamination appeared randomly and almost simultaneously in our two units without any routine change or febrile syndrome, we searched for a common cause. Supplier's sampling kits as well as microbiological laboratory procedures were scrupulously investigated.
21 out of 30 sampling bags filled with sterile water brought back numerous fungi and bacteria. Laboratory's investigation, through the negative control tests performed routinely, exonerated the lab. All batches of bags analyzed later showed variable levels of contamination according to their transport/storage mode or date of manufacturing. Analyses performed by the supplier - methods complying with the medical device's standards but different from those recommended for dialysis fluids purity - remained negative.
Our investigation revealed that the contamination of our sampling kits came presumably from the manufacturer's supplying chain. Such false-positive results findings, created serious safety issues and disturbed clinical activities since positive machines were quarantined. Furthermore, it raised a serious concern about manufacturing, microbiological checking and shipping methods for the medical device industry that deserve further attention.
对于在线透析模式而言,符合透析液超纯度标准至关重要。多年来,我们两个透析单元每月都会分析200多个透析液样本,直至2020年年中微生物检测结果均符合标准。
2020年年中,透析单元中出现异常比例(30%)的受污染透析液,促使我们展开调查以确定源头。
每月对所有透析机的透析液进行嗜水细菌培养和内毒素检测的微生物学方法常规检测。由于污染在我们两个单元中随机且几乎同时出现,且没有任何常规变化或发热综合征,我们寻找共同原因。对供应商的采样试剂盒以及微生物实验室程序进行了严格调查。
30个装有无菌水的采样袋中有21个带回了大量真菌和细菌。通过常规进行的阴性对照试验,实验室调查排除了实验室的问题。后来分析的所有批次的袋子根据其运输/储存方式或生产日期显示出不同程度的污染。供应商进行的分析——方法符合医疗器械标准但与推荐用于透析液纯度检测的方法不同——结果均为阴性。
我们的调查显示,我们采样试剂盒的污染可能来自制造商的供应链。这种假阳性结果引发了严重的安全问题,并干扰了临床活动,因为阳性的机器被隔离了。此外,它引发了对医疗器械行业制造、微生物检查和运输方法的严重关注,值得进一步关注。